Clinical Trial Update: Activity of Abiraterone Acetate in the Management of Cushing's Syndrome in Patients With Adrenocortical Carcinoma [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating abiraterone acetate for managing Cushing's syndrome in patients with adrenocortical carcinoma; current status is not sp…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Adrenocortical Carcinoma
• Cushing Syndrome

Drugs mentioned

• Abiraterone acetate (Abiraterone acetate)

Snippet

Sponsor: Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia | Conditions: Cushing Syndrome, Adrenocortical Carcinoma | Phase 2 | Status: UNKNOWN